NEUVOGEN, Inc. ("NEUVOGEN THERAPEUTICS" or "NEUVOGEN"), a San Diego based biotechnology company, will present data that its next generation whole tumor cell vaccine (NGEN-143) activates T cells that ...

HONG KONG, China I April 18, 2025 I Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that ebdarokimab, an investigational monoclonal ...

Here’s how it works. Finding one of the best cheap cell phone plans no longer means sacrificing data just to keep costs down. I've found ways to keep your bill under $40 each month while still ...

Laboratory of Advanced Optoelectronic Materials, Suzhou Key Laboratory of Novel Semiconductor-Optoelectronics Materials and Devices, State and Local Joint Engineering Laboratory for Novel Functional ...

Maybe he needs to learn a lesson. A former professor at upstate SUNY Canton allegedly took money under the table to dole out higher grades to some of his students, state police said this week.

Cell C has confirmed that data compromised through a cyber attack on its systems in late 2024 has been unlawfully disclosed by RansomHouse, the threat actor who claimed responsibility for the attack.

Children in a West Yorkshire prison were sometimes in cells for more than 20 hours a day and did not get the minimum hours of education, figures have suggested. In January, children at Wetherby ...

Benore Logistic Systems' journey into hydrogen-powered logistics began with a small but significant step in 2022, when it rolled out its first four fuel cell trucks. Building on that success ...

A venture firm in Japan says it has applied to the health ministry for approval to produce and sell sheets of heart muscle cells derived from induced pluripotent stem cells, or iPS cells ...

He decided to take a chance on a clinical trial at Mass Eye and Ear for a procedure that's the first of its kind in the U.S. "The name of it is cultivated autologous limbal epithelial stem cell ...

The company was originally formed with a primary focus on the research of emerging classes of medicines like cell and gene therapies. The startup came out the gate with cash not only from Battelle ...